ABSTRACT
BACKGROUND: In experimental animals, exposure to uncontrollable stress induces a number of behavioral and biochemical changes that resemble symptoms seen in human depression and other psychiatric conditions. The present study used a yoked design to examine the effects of uncontrollable footshock stress on brain thyroid hormones in male and female rats. METHODS: Animals in one group received 15 trials where footshock could be terminated by pressing a lever (escapable shock). Rats in a second group received the same amount of shock, but had no control over shock termination (inescapable shock). Control rats received no shock. RESULTS: No significant differences were found among the three groups, for either males or females, in whole brain levels of thyroxine (T4) 3 hours after the footshock session. In contrast, significant group differences in brain levels of triiodothyronine (T3) were found for both males and females. In males, brain T3 was elevated by 21% in the inescapable shock group when compared to controls (p < .012). In females, brain T3 increased by 19% in the escapable shock group when compared to controls (p < .026). Plasma levels of both T3 and T4 were at control levels for all groups. CONCLUSIONS: These results provide the first demonstration that brain T3 levels change rapidly in response to acute stress. The data further suggest that the effects of stress controllability on brain T3 levels may be different for males and females.
Subject(s)
Brain Chemistry , Stress, Psychological/metabolism , Stress, Psychological/psychology , Thyroxine/analysis , Acute Disease , Animals , Female , Male , Rats , Rats, Sprague-DawleyABSTRACT
The Middle East External Quality Assessment Scheme for Clinical Chemistry has been operating for ten years, during which the number of participants has increased from 32 to 95 in 1990. The success of the Scheme in supporting better health care is reflected in the general improvement in performance of most laboratories. Initially linked to the United Kingdom National External Quality Assessment Scheme, it is anticipated that the Scheme will soon operate independently.
ABSTRACT
The modulation of the immune response by interaction of prolactin and cyclosporin has been investigated in a total of 181 subjects, 121 males and 60 females. This study demonstrates a significant difference in the magnitude and fluctuation in prolactin and cyclosporin concentrations between males and females receiving cyclosporin as the single immunosuppressant. Levels of both analytes are lower in the male and show markedly less fluctuation than in the female. It is proposed that prolactin levels should be taken into account when determining the appropriate dosage regimen of cyclosporin in those patients receiving cyclosporin alone as immunosuppressant therapy.
Subject(s)
Blood Donors , Hepatitis C/ethnology , Egypt/ethnology , Humans , Saudi Arabia/epidemiologyABSTRACT
The fructosamine assay, based on the measurement of the reducing activity in serum at alkaline pH, provides an index of protein glycation. The reducing activity is expressed in equivalents of 1-deoxy-1-morpholinofructose (DMF) by direct comparison with the activity either of this synthetic compound or with a secondary protein standard calibrated against DMF. This study reports the influence of assay timing on the apparent serum fructosamine concentration. The kinetics of alkaline reducing activity in serum differed from that in both DMF and a secondary protein standard. When compared with DMF, activity in serum increased but decreased relative to the protein standard as the pre-incubation interval of the assay was shortened. The use of secondary protein standards results in underestimation of serum fructosamine concentrations when the pre-incubation phase of the assay is shorter than that used for the calibration of the secondary standard. Ascorbate exerted an inhibitory effect in fructosamine assays with pre-incubation times exceeding 5 min. The inhibition increased with both the concentration of ascorbate and the duration of the pre-incubation.
Subject(s)
Hexosamines/blood , Ascorbic Acid/blood , Fructosamine , Humans , Hydrogen-Ion Concentration , Reagent Kits, Diagnostic , Time FactorsABSTRACT
The current HPLC methods of cyclosporin measurement have been reviewed and all aspects assessed. A simple isocratic C-18 reverse phase HPLC method with improved efficiency is described for the routine measurement of cyclosporin in whole blood. An alkaline ether extraction is followed by an acid wash, solvent evaporation and two hexane washes of the reconstituted extract. The turn-round time for a single sample is 1 h. Daily batches of up to 40 patient samples can be easily measured with this method. The results are compared with those from the Sandoz radioimmunoassay (RIA) method.
Subject(s)
Cyclosporins/blood , Chromatography, High Pressure Liquid/methods , Cyclosporins/isolation & purification , Humans , Radioimmunoassay/methodsABSTRACT
The establishment and first 7 years' operation of an external quality assessment scheme for clinical chemistry in the Middle East region are described. The scheme utilises specimens distributed previously in the UK, and the performance of participating laboratories is assessed relative to the UK consensus values, taking account of method. Variance Index scoring has been used to quantitate performance, and there has been an improvement in average scores during the operation of the scheme. There are currently 88 participants, though some laboratories which failed to return results regularly were removed from the scheme. The consensus values from the scheme itself have now been validated, and in future the scheme should operate independently.
Subject(s)
Chemistry, Clinical , Laboratories/standards , Blood Chemical Analysis/methods , Humans , Middle East , Quality Control , Saudi Arabia , United KingdomABSTRACT
Serum fructosamine was measured in 275 blood donors, in 559 subjects with a normal pregnancy, in 32 gestational diabetics being treated with insulin and 69 being treated by diet only, and in 53 pregnant subjects with established diabetes. In none of the pregnant subgroups did the mean fructosamine concentration exceed that of the donor group. The concentration in normal pregnant subjects showed a modest but significant decrease with gestational age and an increase with maternal age. Hyperglycemic non-pregnant subjects (n = 24) had significantly increased serum fructosamine concentrations, and 96% of these subjects exceeded the upper 95% confidence limit for fructosamine in the donor group. A highly significant correlation was demonstrated between serum fructosamine and preprandial plasma glucose in the hyperglycemic subjects. A weak, but significant, correlation was shown for the entire population sample of antenatal patients, while this was non-significant within each of the sub-groups comprising established diabetics and gestational diabetics, respectively.
Subject(s)
Hexosamines/blood , Pregnancy in Diabetics/blood , Adult , Blood Glucose/metabolism , Female , Fructosamine , Glycation End Products, Advanced , Glycosylation , Humans , Insulin/therapeutic use , Pregnancy , Pregnancy in Diabetics/drug therapy , Reference Values , Regression Analysis , Serum Albumin/metabolism , Glycated Serum AlbuminABSTRACT
The association process of glucagon receptor binding in purified rat liver plasma membranes and prolonged incubation of the hormone-receptor complex at 30 degrees C did not result in degradation of bound labelled glucagon. In contrast, up to 95% of the non-membrane-bound labelled glucagon was degraded. The rate of spontaneous dissociation of the glucagon-receptor complex was slow, and amounted to about 0.1% per min of that bound. GTP greatly enhanced the rate of dissociation. Half the maximal dissociation of the complex was effected by 10(-5) mol/l of GTP under equilibrium binding conditions. At maximally effective concentrations of GTP, 80% of the glucagon-receptor complex was dissociated within 2 min. A microperifusion system for the perifusion of isolated plasma membranes was devised and used for the separation of labelled glucagon from the plasma membranes subsequent to a GTP-induced dissociation of the hormone-receptor complex. Rebinding of the dissociated peptide to fresh membranes showed that maximum binding ability was retained. The glucagon molecule was protected against degradation while bound to the receptor, indicating that the glucagon effector system is completely separate from the inactivating system(s) in isolated plasma membranes. Thus, the hormonal effect of glucagon could be exerted through the sequential interaction of each glucagon molecule with several receptors.
Subject(s)
Cell Membrane/metabolism , Glucagon/metabolism , Liver/metabolism , Receptors, Gastrointestinal Hormone/metabolism , Animals , Guanosine Triphosphate/pharmacology , Kinetics , Peptide Hydrolases/metabolism , Protein Binding , Rats , Rats, Inbred Strains , Receptors, Gastrointestinal Hormone/drug effects , Receptors, GlucagonABSTRACT
A new, simple insulin-receptor-binding assay has been devised. The assay is based on the separation of free and receptor-bound 125I-labeled insulin in 80% ethanol. It was found that the insulin-receptor complex was fully stable at this ethanol concentration, regardless of the source of the receptor employed. The assay has been evaluated with solubilized insulin receptors and membrane-bound receptors from human placenta and porcine liver as well as intact cells with the IM-9 cell line. The assay is simple, rapid, and has large capacity. Comparisons of the ethanol-based assay to the conventionally employed assays with polyethylene glycol or microfuge centrifugation for the separation of free and bound 125I-insulin revealed large discrepancies between the assays. The ethanol-based assay always appeared to provide a better separation. Microfuge centrifugation of placental membranes precipitated approximately 3% of the ethanol-precipitable insulin-receptor complex, while polyethylene glycol precipitation of solubilized insulin receptors varied between 40 and 80% of the ethanol precipitability, depending on the receptor concentration employed.
Subject(s)
Receptor, Insulin/analysis , Cell Membrane/metabolism , Centrifugation , Chemical Precipitation , Ethanol , Humans , Insulin/metabolism , Liver/analysis , Lymphocytes/analysis , Placenta/analysis , Polyethylene GlycolsABSTRACT
The HLA-A, -B, -C, -DR, Bf and GLO phenotypes of 109 unrelated Saudi Arab males have been determined. HLA-A and -B antigen frequencies were compared with data reported for European Caucasoids and various Arab populations. Most similarities in antigen frequencies were seen between Saudi Arab and Iraqi populations. A high frequency of Bw50 was observed in Saudi Arabs. The frequencies of HLA-DR antigens in Saudi Arabs were compared to European Caucasoids. HLA-DR7 was at high frequency in Saudi Arabs. Linkage disequilibria between alleles of HLA loci was examined. Many instances of previously reported antigen associations were seen in Saudi Arabs, together with a number of associations which have not been described elsewhere. HLA-Cw6-Bw50-DR7-BfS0.7 is suggested as being a common haplotype in Saudi Arabs.
Subject(s)
HLA Antigens/genetics , Polymorphism, Genetic , Complement Factor B/genetics , Europe , Gene Frequency , Genetic Linkage , HLA-DR Antigens , Histocompatibility Antigens Class II/genetics , Humans , Lactoylglutathione Lyase/genetics , Male , Saudi Arabia , White PeopleABSTRACT
The Sunnybrook Gallstone Study was a randomized, double-blind, controlled trial of chenodeoxycholic acid treatment over 2 years in 160 patients with radiolucent gallstones. Sixty-four patients received 750 mg daily, 53 received 375 mg daily and 43 received placebo. Total dissolution of gallstones occurred in 10.9% of patients on 750 mg daily, 13.2% of those on 375 mg daily and in no patient on placebo. The drug was tolerated well. Diarrhea severe enough to cause withdrawal from the study occurred in two patients. No patient developed clinically significant hepatotoxicity. Serum cholesterol rose 10% or more above baseline after 2 years in 33% of patients treated with chenodeoxycholic acid and in 30% of those on placebo. Cholecystectomy was performed in 10.9% of patients on 750 mg daily, 17% on 375 mg daily and 13.6% on placebo. Chenodeoxycholic acid given at these doses dissolved radiolucent gallstones safely but the efficacy was limited.
Subject(s)
Chenodeoxycholic Acid/therapeutic use , Cholelithiasis/drug therapy , Adult , Aged , Canada , Clinical Trials as Topic , Double-Blind Method , Drug Evaluation , Female , Humans , Male , Middle AgedABSTRACT
The distribution of properdin factor B (Bf) phenotypes and the gene frequencies were investigated in 918 Saudi Arabs. A high frequency of the 'rare' allele BFS0.7 was observed BfS0.7 = 0.1514). The frequencies of the common Bf alleles (BfS = 0.5174, BfF = 0.3213) are outside the corresponding ranges of BfS, BfF gene frequencies found in European Caucasoids.
Subject(s)
Complement Factor B/genetics , Enzyme Precursors/genetics , Alleles , Ethnicity , Female , Gene Frequency , Humans , Male , Polymorphism, Genetic , Pregnancy , Saudi ArabiaABSTRACT
This study has found low 24-h urine volumes in British expatriates in Saudi Arabia and suggests the possibility of urate stone formation in spite of the air-conditioned environment in which they were living. Urine volume was shown to be significantly correlated with calcium excretion in both sexes and to urate and sodium in males. Differences in 24-h urine concentrations of some but not all constituents between British-born subjects living in Britain and Saudi Arabia have been demonstrated.
Subject(s)
Electrolytes/urine , Environment , Urine , Adult , Calcium/urine , Female , Humans , Male , Middle Aged , Osmolar Concentration , Saudi Arabia , Sex Factors , Sodium/urine , United Kingdom/ethnology , Uric Acid/urineABSTRACT
The prevalence of diabetes mellitus in 1385 males in the Al-Kharj area of Saudi Arabia was studied using the WHO criteria for screening and interpretation of glucose tolerance tests[1]. The prevalence was found to increase with age. No diabetic patients were found in the less than or equal to 24 year age group and only one (0.3%) in the age range: 25-34 years. There were seven (2.6%) in the age range: 35-44 years, 17 (9.6%) in the age range: 45-54 years, six (11%) in the age range: 55-64 years and three (23%) in the age range: greater than or equal to 65 years. The cases detected were relatively symptom free, but 65% of the diabetic patients were overweight.